Muscarinic agonists for the treatment of cognition in schizophrenia
about
Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicologyClinical features of organophosphate poisoning: A review of different classification systems and approachesRNA deep sequencing analysis reveals that nicotine restores impaired gene expression by viral proteins in the brains of HIV-1 transgenic ratsNew translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and ratsReduction of [11C](+)3-MPB binding in brain of chronic fatigue syndrome with serum autoantibody against muscarinic cholinergic receptor.Past and present progress in the pharmacologic treatment of schizophrenia.Muscarinic receptor occupancy and cognitive impairment: a PET study with [11C](+)3-MPB and scopolamine in conscious monkeys.Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.Intact attentional processing but abnormal responding in M1 muscarinic receptor-deficient mice using an automated touchscreen method.Use of cerebrospinal fluid biomarkers in clinical trials for schizophrenia and depression.Novel M(1) allosteric ligands: a patent review.Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia.Structural determinants for the interactions between muscarinic toxin 7 and muscarinic acetylcholine receptors.Discovery of potential antipsychotic agents possessing pro-cognitive properties.Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmine.The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia.HT1001, a proprietary North American ginseng extract, improves working memory in schizophrenia: a double-blind, placebo-controlled study.Validation of reference tissue model of PET ligand [¹¹C]+3-MPB for the muscarinic cholinergic receptor in the living brain of conscious monkey.M1 muscarinic cetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer's disease
P2860
Q24627240-8DDFB780-D9C8-4A48-ADEE-95068E66D541Q28397902-44C2391C-9456-4707-9173-04A147AC6ECBQ30418181-0A3D3944-974F-4883-A6A4-B37EE6D24A88Q34181201-E7609E90-1462-4DE4-92C4-9FBE2E630198Q34512441-DC68455E-B308-4AA7-8B7E-4A27AC29D4E9Q34726953-ECD5BCA3-6E4B-43B7-BC21-E3C64C41E0BAQ34988437-7EE4817B-402D-4D13-8EB6-1DD3395F11F2Q35048154-E17F8C48-46DB-4EF9-A1E3-B449557FDC99Q37506679-FF8A9D84-7E5C-4389-86F2-E82D59D8CAEDQ37980501-0C1E6D1B-5062-482D-802F-C951DC7F062DQ38054855-83039A0B-8F2D-4B06-B19A-9820AA0310B0Q38170140-B5E5DED0-8D75-4073-8938-6E0EBDD87098Q41434167-2477FC3E-D74B-4248-A9E3-391B927CA445Q42803307-06918BFB-DBE5-4124-BE49-AF169F4A06B7Q43152159-64D58903-5670-4CCD-A6F2-8B68448D10D6Q47133877-F2438307-AA62-449F-874D-502F757F1478Q50774349-A566CEAB-541C-4D25-A2DF-D07DC6304266Q51829340-E75FAF99-3F38-4E1D-BE58-19703D33D755Q58856223-4201769F-95EB-458B-A989-71D8A0386B5F
P2860
Muscarinic agonists for the treatment of cognition in schizophrenia
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Muscarinic agonists for the treatment of cognition in schizophrenia
@ast
Muscarinic agonists for the treatment of cognition in schizophrenia
@en
Muscarinic agonists for the treatment of cognition in schizophrenia
@nl
type
label
Muscarinic agonists for the treatment of cognition in schizophrenia
@ast
Muscarinic agonists for the treatment of cognition in schizophrenia
@en
Muscarinic agonists for the treatment of cognition in schizophrenia
@nl
prefLabel
Muscarinic agonists for the treatment of cognition in schizophrenia
@ast
Muscarinic agonists for the treatment of cognition in schizophrenia
@en
Muscarinic agonists for the treatment of cognition in schizophrenia
@nl
P2093
P2860
P1433
P1476
Muscarinic agonists for the treatment of cognition in schizophrenia
@en
P2093
Angela K Sellin
Carol Tamminga
Mujeeb Shad
P2860
P304
P356
10.1017/S1092852900014048
P407
P577
2008-11-01T00:00:00Z